diabetic kidney disease
Showing 1 - 25 of 98
Diabetic Kidney Disease Trial (Soleus ms exercise)
Not yet recruiting
- Diabetic Kidney Disease
- Soleus ms exercise
- (no location specified)
Nov 4, 2023
Revealing Engagement Dynamics Among Diabetic Kidney Disease
Not yet recruiting
- Diabetic Kidney Disease
-
San Francisco, CaliforniaPower Life Sciences
Oct 20, 2023
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Not yet recruiting
- Diabetic Kidney Disease
- cathepsin S and chromogranin A
- (no location specified)
Oct 5, 2023
Thickening of Bowman's Capsule on Clinical Prognosis of Diabetic
Not yet recruiting
- Diabetic Kidney Disease
- Extracellular Matrix Alteration
- no intervention
- (no location specified)
Sep 15, 2023
Diabetic Kidney Disease Trial in China (Qishen Yiqi Dripping Pills 3 bags, Low dose Qishen Yiqi Dripping Pills 3 bags, High
Not yet recruiting
- Diabetic Kidney Disease
- Qishen Yiqi Dripping Pills placebo 3 bags
- +2 more
-
Beijing, Beijing, China
- +15 more
Aug 22, 2023
A Long-Term Follow-Up Study of Participants Exposed to REACT
Not yet recruiting
- Diabetic Kidney Disease
- Chronic Kidney Diseases
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jun 15, 2023
Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,
Recruiting
- Diabetic Kidney Disease
- ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
-
Herlev, DenmarkDepartment of Nephrology, Herlev and Gentofte Hospital
May 31, 2023
Technology and Clinical Transformation of Type 2 Diabetes
Recruiting
- Diabetic Nephropathy Type 2
- +2 more
-
Beijing, ChinaChinese PLA General Hospital
May 25, 2023
Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)
Not yet recruiting
- Diabetic Kidney Disease
- Type 1 Diabetes
- Semaglutide
- Placebo
- (no location specified)
Apr 18, 2023
Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)
Not yet recruiting
- Type2diabetes
- Diabetic Kidney Disease
- Investigational Product - MIB 626
- Placebo
- (no location specified)
Mar 6, 2023
Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)
Recruiting
- Proteinuria
- +3 more
-
Hanzhou, Zhejiang, Chinathe Second Afficiated Hospital, Zhejiang University, School of M
Feb 22, 2023
Diabetes, Diabetic Kidney Disease, Hypertension Trial (Salt-Diet and/or Ertugliflozin)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- Salt-Diet and/or Ertugliflozin
- (no location specified)
Feb 3, 2023
Diabetic Kidney Disease, CAKUT, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT))
Not yet recruiting
- Diabetic Kidney Disease
- +2 more
- Renal Autologous Cell Therapy (REACT)
- (no location specified)
Jan 11, 2023
Diabetic Kidney Disease, IgA Nephropathy Trial (Placebo of SC0062, SC0062 low dose, SC0062 medium dose)
Not yet recruiting
- Diabetic Kidney Disease
- IgA Nephropathy
- Placebo of SC0062
- +3 more
- (no location specified)
Jan 9, 2023
Diabetic Kidney Disease Trial in Beijing (SPH3127+SPH3127matching +valsartan matching , SPH3127+valsartan matching , SPH3127
Not yet recruiting
- Diabetic Kidney Disease
- SPH3127+SPH3127matching placebo+valsartan matching placebo
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 9, 2023
Diabetic Kidney Disease Trial in Taichung City (Probiotic group, Placebo group)
Not yet recruiting
- Diabetic Kidney Disease
- Probiotic group
- Placebo group
-
Taichung City, TaiwanChung Shan Medical University Hospital
Dec 29, 2022
Diabetic Kidney Disease, Diabetes Type 2, Chronic Kidney Diseases Trial
Not yet recruiting
- Diabetic Kidney Disease
- +3 more
- (no location specified)
Nov 23, 2022
Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)
Recruiting
- Diabetes Mellitus
- Diabetic Kidney Disease
- Dulaglutide
- +2 more
-
Sha Tin, Hong KongPrince of Wales Hospital
Nov 8, 2022
Kidney Disease in Type 1 Diabetes:Modern Kidney Biopsy Cohort
Not yet recruiting
- Type 1 Diabetes
- +4 more
- Aminohippurate Sodium Inj 20% Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)
- Iohexol Inj 300 MG/ML Diagnostic aid/agent used to measure glomerular filtration rate (GFR)
-
Aurora, ColoradoChildren's Hospital Colorado
Sep 8, 2022
Chronic Kidney Disease (CKD) With Diabetes (DM), CKD Stage 3, CKD Stage 4 Trial (PLAFOND diet)
Not yet recruiting
- Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM)
- +5 more
- PLAFOND diet
- (no location specified)
Aug 21, 2022
Type 2 Diabetes, Diabetic Kidney Disease Trial in Aurora, Boston, Ann Arbor (canagliflozin, Aminohippurate Sodium Inj 20%)
Recruiting
- Type 2 Diabetes
- Diabetic Kidney Disease
- canagliflozin
- Aminohippurate Sodium Inj 20%
-
Aurora, Colorado
- +3 more
Aug 17, 2022